Terms: = Head and neck cancer AND OMD, osteoadherin, 4958, ENSG00000127083, Q99983, SLRR2C
11 results:
1. Oncological outcomes of patients with oligometastatic oesophagogastric cancer.
Down B; Lakunina S; Maynard N; Markar SR; Gordon-Weeks A
Eur J Surg Oncol; 2024 Apr; 50(4):108231. PubMed ID: 38461569
[TBL] [Abstract] [Full Text] [Related]
2. Stereotactic radiotherapy in the management of oligometastatic and recurrent head and neck cancer: a single-center experience.
Mohamed AA; Goncalves M; Singh BP; Tometten M; Rashad A; Hölzle F; Hackenberg S; Eble M
Strahlenther Onkol; 2024 May; 200(5):400-408. PubMed ID: 38063900
[TBL] [Abstract] [Full Text] [Related]
3. Outcomes for oligometastatic head and neck cancer treated with stereotactic body radiotherapy: Results from an international multi-institutional consortium.
Id Said B; Mutsaers A; Chen H; Husain ZA; Biswas T; Dagan R; Erler D; Foote M; Louie AV; Redmond K; Ricardi U; Sahgal A; Poon I
Head Neck; 2023 Oct; 45(10):2627-2637. PubMed ID: 37602655
[TBL] [Abstract] [Full Text] [Related]
4. Management of Oligometastatic Disease in Esophagogastric cancer: What Is the Evidence?
Hingorani M; Stubley H
Oncol Res Treat; 2023; 46(7-8):312-319. PubMed ID: 37331340
[TBL] [Abstract] [Full Text] [Related]
5. Incidence and survival of patients with oligometastatic esophagogastric cancer: A multicenter cohort study.
Kroese TE; Christ SM; van Rossum PSN; Burger MDL; Buijs GS; Mühlematter U; Andratschke N; Ruurda JP; Hüllner M; Gutschow CA; van Hillegersberg R; Guckenberger M
Radiother Oncol; 2022 Aug; 173():269-276. PubMed ID: 35753555
[TBL] [Abstract] [Full Text] [Related]
6. Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric cancer.
Kroese TE; Buijs GS; Burger MDL; Ruurda JP; Mook S; Brosens LAA; van Rossum PSN; van Hillegersberg R
Ann Surg Oncol; 2022 Aug; 29(8):4848-4857. PubMed ID: 35381938
[TBL] [Abstract] [Full Text] [Related]
7. Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: A systematic review and meta-analysis.
Kroese TE; van Laarhoven HWM; Nilsson M; Lordick F; Guckenberger M; Ruurda JP; D'Ugo D; Haustermans K; van Cutsem E; van Hillegersberg R; van Rossum PSN
Eur J Cancer; 2022 May; 166():254-269. PubMed ID: 35339868
[TBL] [Abstract] [Full Text] [Related]
8. [Study on the oral mucosal diseases in patients with cerebrovascular diseases].
Jin JQ; Li W; Mu YL; Jiang Y; Zhang YX; Lu ZY
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Aug; 40(8):1003-1005. PubMed ID: 31484269
[No Abstract] [Full Text] [Related]
9. Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients.
de Vos L; Gevensleben H; Schröck A; Franzen A; Kristiansen G; Bootz F; Dietrich D
Clin Epigenetics; 2017; 9():125. PubMed ID: 29213339
[TBL] [Abstract] [Full Text] [Related]
10. Genetic Predictors of Response to Systemic Therapy in Esophagogastric cancer.
Janjigian YY; Sanchez-Vega F; Jonsson P; Chatila WK; Hechtman JF; Ku GY; Riches JC; Tuvy Y; Kundra R; Bouvier N; Vakiani E; Gao J; Heins ZJ; Gross BE; Kelsen DP; Zhang L; Strong VE; Schattner M; Gerdes H; Coit DG; Bains M; Stadler ZK; Rusch VW; Jones DR; Molena D; Shia J; Robson ME; Capanu M; Middha S; Zehir A; Hyman DM; Scaltriti M; Ladanyi M; Rosen N; Ilson DH; Berger MF; Tang L; Taylor BS; Solit DB; Schultz N
Cancer Discov; 2018 Jan; 8(1):49-58. PubMed ID: 29122777
[TBL] [Abstract] [Full Text] [Related]
11. Esophageal cancer Epigenomics and Integrome Analysis of Genome-Wide Methylation and Expression in High Risk Northeast Indian Population.
Singh V; Singh LC; Vasudevan M; Chattopadhyay I; Borthakar BB; Rai AK; Phukan RK; Sharma J; Mahanta J; Kataki AC; Kapur S; Saxena S
OMICS; 2015 Nov; 19(11):688-99. PubMed ID: 26496483
[TBL] [Abstract] [Full Text] [Related]
